Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-21-129572

Options or other derivatives

  • CEO and President acquired 50,041 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Russo Rene · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-21 Grant or award : show line 1 in the form Stock Option (right to buy) +50,041 50,041 D
Loading xslF345X03/tm2130646-23_4seq1.xml…